secobarbital will reduce the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Consider an increase in cannabidiol dosage (determined by medical response and tolerability) when coadministered with a strong CYP3A4 inducer.Dependant on newly compiled facts from Academy clinicians, t